Moderated by Gopal Karemore, Director, Novo Nordisk Gopal Karemore is a director at the digital research & intelligence wing of Novo Nordisk A/S in Denmark. He has PhD in computer science from Univ. of Copenhagen with 14+ years of experience in data science, statistics, modelling, machine learning, visualisation, and quantum computing within early research, preclinical, and clinical pharmaceutical settings. He co-authored 35+ research articles published in high-impact scientific journals, e.g. Nature, iScience, IEEE, and was involved in shaping strategic initiatives and business development within pharmaceutical R&D processes. Before Novo Nordisk, he worked with various industries such as Philips, GE research, Siemens Corporate Research, University of Pennsylvania, Spanish National Center for Cardiovascular Research and Novo Nordisk Foundation Centers for Protein Research & Stem Cell Biology.  Panelists: Clemens Utschig-Utschig, CTO, Boehringer Ingelheim Bhushan Bonde, Head of Innovation for In-silico R&D, Drug Discovery, Evotec Zoran Krunic, Sr Manager, Data Science, Amgen Peyman Moh, Director, Former Digital Health and Innovation, Global Tech, GSK Jens Kieckbusch, Associate Director, Emerging Innovations Emerging Innovations Unit, Astra Zeneca